EarningsQ2 2025 Earnings Report

Alnylam Pharma (ALNY) Q2 2025 Earnings Report

0 Followers

MX:ALNY Q2 2025 EPS Results

Actual EPS-$9.39

Consensus EPS-$10.02

Beat/MissBeat by +$0.63

One Year Ago EPS-$2.39

Actual Revenue$14.25B

Expected Revenue$12.21B

Beat/MissBeat by +$2.04B

YoY Revenue Growth+17.26%

QuarterQ2 2025

Date07/31/2025

TimeBefore Open

Conference CallThursday, July 31, 2025

MX:ALNY Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:ALNY Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	32.19 / -	33.882	―
Jul 30, 2026	2026 (Q2)	30.02 / 22.28	-9.391	337.25% (+31.67)
Apr 30, 2026	2026 (Q1)	16.06 / 27.81	-8.102	443.18% (+35.91)
Feb 12, 2026	2025 (Q4)	21.18 / 15.10	-11.969	226.15% (+27.07)
Oct 30, 2025	2025 (Q3)	10.33 / 33.88	-16.02	311.49% (+49.90)
Jul 31, 2025	2025 (Q2)	-10.02 / -9.39	-2.394	-292.31% (-7.00)
May 01, 2025	2025 (Q1)	-16.39 / -8.10	-9.575	15.38% (+1.47)
Feb 13, 2025	2024 (Q4)	-10.90 / -11.97	-20.256	40.91% (+8.29)
Oct 31, 2024	2024 (Q3)	-16.89 / -16.02	21.176	-175.65% (-37.20)
Aug 01, 2024	2024 (Q2)	-19.65 / -2.39	-40.695	94.12% (+38.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed